AAC17_JenniferYearleyBlog

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

In Americas, Antibodies by Karina KusovaLeave a Comment

Jennifery Yearley of Merck joined us for Americas Antibody Congress 2016 to discuss ‘PD-L2 expression in human tumors’

In this presentation, learn about how PD-L2 expression in human tumors relates to Anti-PD-1 therapy in cancer.

Download this presentation to understand more about:

  • Programmed Cell Death 1 (PD-1) and Pembrolizumab
  • PD-L2 Function as it relates to health & disease
  • PD-L2 in normal human tissues
  • PD-L2 in human tumors

and much more !

Get your copy here !

If you’re interested in learning more about the relationship between antibodies and treatments for cancers and other diseases , join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA. This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA .

Learn more about Americas Antibody Congress

Leave a Comment

Current ye@r *